Skip to main content
. 2015 Mar 6;18(7):pyu120. doi: 10.1093/ijnp/pyu120

Table 1.

Clinical and demographic characteristics of the participants

Healthy controls
(n = 39)
MDD
(n =39)
Healthy controls vs MDD MDD (n = 39) Responders vs nonresponders vs dropout MDD
Responders
(n = 12)
Nonresponders
(n = 9)
Dropout MDD
(n = 18)
%, n %, n χ2 (df = 1) p %, n %, n %, n χ2 (df = 2) p a
Male, % (male/female) 38.9% (21/18) 51.3% (20/19) 0.05 0.82 66.7% (8/4) 55.6% (5/4) 38.9 % (7/11) 2.28 0.33
Smoker, % (smoker/nonsmoker) 12.8% (5/34) 41.0% (16/23) 7.89 0.005** 50.0% (6/6) 44.4% (4/5) 33.3% (6/12) 0.88 0.70
First episode, % (first/recurrent) - 56.4% (22/17) - - 66.7% (8/4) 77.8% (7/2) 38.9 (7/11) 4.22 0.13
Antidepressant
Paroxetine - 22 (56.4) - - 9 (75.0) 6 (66.7) 7 (38.9) 4.56 0.30
Venlafaxine - 15 (38.5) 3 (25.0) 3 (33.3) 9 (50.0)
Duloxetine - 2 (5.1) 0 0 2 (11.1)
Mean ± SD Mean ± SD t (df = 1) p Mean ± SD Mean ± SD Mean ± SD F (df = 2) p
Age (years) 32.3±8.3 34.3±11.5 -0.88 0.38 35.1±13.2 33.4±8.5 34.2±12.1 0.05 0.95
Onset age (years) - 28.4±9.8 - - 31.1±10.9 31.8±7.6 24.9±9.3 2.24 0.12
Education (years) 16.5±2.1 13.9±2.7 4.65 <0.001*** 14.2±1.7 14.6±1.8 13.2±3.5 0.85 0.44
Body mass index (kg/m2). 23.4±3.5 22.7±3.5 0.85 0.40 23.5±4.1 23.1±3.4 22.0±3.2 0.70 0.51
Number of MDE - 1.7±0.9 - - 1.4±0.7 1.2±0.4 2.1±1.1 3.72 0.03*
Number of suicide attempts - 0.9±1.3 - - 0.4±0.9 1.0±1.5 1.1±1.5 1.05 0.36
Baseline HDRS score 0.4±1.1 27.8±5.4 -30.8 <0.001*** 26.5±5.1 26.8±4.1 29.2±6.2 1.07 0.35
Dose of 4-[18F]-ADAM (mCi) 8.1±1.2 7.8±1.0 1.28 0.20 7.8±0.8 8.1±0.9 7.6±1.2 0.60 0.55

MDD, major depressive disorder; MDE, major depressive episode; HDRS, 21-item Hamilton Depression Rating Scale; SD, standard deviation; df: degree of freedom. Bold numbers indicate significance.

a Fisher’s exact test.

*p<0.05, **p<0.01, ***p<0.001 is considered as significant.